Lower Vitamin D levels are associated with higher systemic lupus erythematosus activity, but not predictive of disease flare-up

Lupus Science and Medicine

Volumn 1, Issue 1, 2014, Pages

  Schoindre, Yoland ^a,b   Jallouli, Moez ^a,b   Tanguy, Marie Laure ^b   Ghillani, Pascale ^b   Galicier, Lionel ^c,d   Aumaître, Olivier ^e,f   Francès, Camille ^a,g   Le Guern, Véronique ^c,h   Lioté, Frédéric ^c,i   Smail, Amar ^j   Limal, Nicolas ^k   Perard, Laurent ^l   Desmurs Clavel, Hélène ^l   Le Thi Huong, Du ^a,b   Asli, Bouchra ^c,d   Kahn, Jean Emmanuel ^m   Sailler, Laurent ^n,o   Ackermann, Félix ^m   Papo, Thomas ^c,p   Sacré, Karim ^c,p   Fain, Olivier ^q,r   Stirnemann, Jérôme ^q,r   Cacoub, Patrice ^a,b   Leroux, Gaëlle ^a,b   Cohen Bittan, Judith ^a,b   Hulot, Jean Sébastien ^a,b   Lechat, Philippe ^a,b   Musset, Lucile ^b   Piette, Jean Charles ^a,b   Amoura, Zahir ⁱ   Souberbielle, Jean Claude ^c,s   Costedoat Chalumeau, Nathalie ^a,b   Astudillo, Leonardo ^t   Belizna, Cristina ^t   Belmatoug, Nadia ^t   Benveniste, Olivier ^t   Benyamine, Audrey ^t   Bezanahary, Holly ^t   Blanco, Patrick ^t   Bletry, Olivier ^t   Bodaghi, Bahram ^t   Bourgeois, Pierre ^t   Brihaye, Benoît ^t   Chatelus, Emmanuel ^t   Damade, Richard ^t   Daugas, Eric ^t   De Gennes, Christian ^t   Delfraissy, Jean François ^t   Delluc, Céline ^t   Delluc, Aurélien ^t   Duhaut, Pierre ^t   Dupuy, Alain ^t   Durieu, Isabelle ^t   Ea, Hang Korng ^t   Farge, Dominique ^t   Funck Brentano, Christian ^t   Gandjbakhch, Frédérique ^t   Gellen Dautremer, Justine ^t   Godeau, Bertrand ^t   Goujard, Cécile ^t   Grandpeix, Catherine ^t   Grange, Claire ^t   Grimaldi, Lamiae ^t   Guettrot, Gaëlle ^t   Guillevin, Loïc ^t   Hachulla, Eric ^t   Harle, Jean Robert ^t   Haroche, Julien ^t   Hausfater, Pierre ^t   Jouquan, Jean ^t   Kaplanski, Gilles ^t   Keshtmand, Homa ^t   Khellaf, Mehdi ^t   Lambotte, Olivier ^t   Launay, David ^t   Levesque, Hervé ^t   Lidove, Olivier ^t   Liozon, Eric ^t   Ly, Kim ^t   Mahevas, Matthieu ^t   Mariampillai, Kubéraka ^t   Mariette, Xavier ^t   Mathian, Alexis ^t   Mazodier, Karin ^t   Michel, Marc ^t   Morel, Nathalie ^t   Mouthon, Luc ^t   Ngack, Rokiya ^t   Ninet, Jacques ^t   Oksenhendler, Eric ^t   Pellegrin, Jean Luc ^t   Peyr, Olivier ^t   Piette, Anne Marie ^t   Poindron, Vincent ^t   Pourrat, Jacques ^t   Roux, Fabienne ^t   Saadoun, David ^t   Sahali, Sabrinel ^t   Saint Marcoux, Bernadette ^t   Sarrot Reynauld, Françoise ^t   Sellam, Jérémie ^t   Sene, Damien ^t   Serratrice, Jacques ^t   Seve, Pascal ^t   Sibilia, Jean ^t   Simon, Claude ^t   Sordet, Christelle ^t   Terrier, Benjamin ^t   Trad, Salim ^t   Viallard, Jean François ^t   Vidal, Elisabeth ^t   Wechsler, Bertrand ^t   Weiller, Pierre Jean ^t   Zahr, Noël ^t   more..

^a SORBONNE UNIVERSITÉ   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d SAINT LOUIS HOSPITAL   (France)

^e UNIVERSITÉ CLERMONT AUVERGNE   (France)

^f SERVICE DE RHUMATOLOGIE   (France)

^g HÔPITAL TENON   (France)

^h Université de Clermont Ferrand ^*  (France)

ⁱ HÔPITAL LARIBOISIÈRE   (France)

^j AMIENS UNIVERSITY HOSPITAL   (France)

^k HENRI MONDOR HOSPITAL   (France)

^l EDOUARD HERRIOT HOSPITAL   (France)

^m LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

ⁿ UNIVERSITÉ PAUL SABATIER   (France)

^o CHU PURPAN   (France)

^p BICHAT HOSPITAL   (France)

^q UNIVERSITÉ PARIS 13   (France)

^r HÔPITAL JEAN VERDIER   (France)

^s HÔPITAL NECKER ENFANTS MALADES   (France)

^t NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ANTICOAGULANT AGENT; COMPLEMENT COMPONENT C3; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ADULT; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BODY MASS; CREATININE CLEARANCE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; ETHNICITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENCE FREE SURVIVAL; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; VISUAL ANALOG SCALE; VITAMIN BLOOD LEVEL;

EID: 84937786037     PISSN: None     EISSN: 20538790     Source Type: Journal    
DOI: 10.1136/lupus-2014-000027     Document Type: Article

References (53)

1. Schoindre Y, Terrier B, Kahn JE, et al. [Vitamin D and autoimmunity. First part: fundamental aspects]. Rev Med Interne 2012;33:80-6.
2. Lemire JM, Ince A, Takashima M. 1,25-Dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL/l mice. Autoimmunity 1992;12:143-8.
3. Abe J, Nakamura K, Takita Y, et al. Prevention of immunological disorders in MRL/l mice by a new synthetic analogue of vitamin D3: 22-oxa-1 alpha, 25-dihydroxyvitamin D3. J Nutr Sci Vitaminol (Tokyo) 1990;36:21-31.
4. Koizumi T, Nakao Y, Matsui T, et al. Effects of corticosteroid and 1,24R-dihydroxy-vitamin D3 administration on lymphoproliferation and autoimmune disease in MRL/MP-lpr/lpr mice. Int Arch Allergy Appl Immunol 1985;77:396-404.
5. Deluca HF, Cantorna MT. Vitamin D: its role and uses in immunology. FASEB J 2001;15:2579-85.
6. Linker-Israeli M, Elstner E, Klinenberg JR, et al. Vitamin D(3) and its synthetic analogs inhibit the spontaneous in vitro immunoglobulin production by SLE-derived PBMC. Clin Immunol 2001;99:82-93.
7. Ritterhouse LL, Crowe SR, Niewold TB, et al. Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus. Ann Rheum Dis 2011;70:1569-74.
8. Terrier B, Derian N, Schoindre Y, et al. Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation. Arthritis Res Ther 2012;14:R221.
9. Ben-Zvi I, Aranow C, Mackay M, et al. The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus. PLoS ONE 2010;5:e9193.
10. Ozaki Y, Nomura S, Nagahama M, et al. Vitamin-D receptor genotype and renal disorder in Japanese patients with systemic lupus erythematosus. Nephron 2000;85:86-91.
11. Huang CM, Wu MC, Wu JY, et al. Association of vitamin D receptor gene BsmI polymorphisms in Chinese patients with systemic lupus erythematosus. Lupus 2002;11:31-4.
12. Kamen DL, Cooper GS, Bouali H, et al. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 2006;5:114-17.
13. Wu PW, Rhew EY, Dyer AR, et al. 25-hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus erythematosus. Arthritis Rheum 2009;61:1387-95.
14. Muller K, Kriegbaum NJ, Baslund B, et al. Vitamin D3 metabolism in patients with rheumatic diseases: low serum levels of 25-hydroxyvitamin D3 in patients with systemic lupus erythematosus. Clin Rheumatol 1995;14:397-400.
15. Chen S, Sims GP, Chen XX, et al. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 2007;179:1634-47.
16. Wright TB, Shults J, Leonard MB, et al. Hypovitaminosis D is associated with greater body mass index and disease activity in pediatric systemic lupus erythematosus. J Pediatr 2009; 155:260-5.
17. Amital H, Szekanecz Z, Szucs G, et al. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis 2010;69:1155-7.
18. Cutolo M, Otsa K. Review: vitamin D, immunity and lupus. Lupus 2008;17:6-10.
19. Borba VZ, Vieira JG, Kasamatsu T, et al. Vitamin D deficiency in patients with active systemic lupus erythematosus. Osteoporos Int 2009;20:427-33.
20. Costedoat-Chalumeau N, Galicier L, Aumaitre O, et al. Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study). Ann Rheum Dis 2013;72:1786-92.
21. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
22. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306.
23. Costedoat-Chalumeau N, Amoura Z, Hulot JS, et al. Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus. Arthritis Rheum 2006;54:3284-90.
24. Petri M, Kim MY, Kalunian KC, et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 2005;353:2550-8.
25. Hollis BW, Kamerud JQ, Selvaag SR, et al. Determination of vitamin D status by radioimmunoassay with an 125I-labeled tracer. Clin Chem 1993;39:529-33.
26. Ruiz-Irastorza G, Egurbide MV, Olivares N, et al. Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. Rheumatology (Oxford) 2008;47:920-3.
27. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-81.
28. Huisman AM, White KP, Algra A, et al. Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J Rheumatol 2001;28:2535-9.
29. Carnevale V, Modoni S, Pileri M, et al. Longitudinal evaluation of vitamin D status in healthy subjects from southern Italy: seasonal and gender differences. Osteoporos Int 2001;12:1026-30.
30. Mithal A, Wahl DA, Bonjour JP, et al. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 2009;20:1807-20.
31. Chonchol M, Scragg R. 25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey. Kidney Int 2007;71:134-9.
32. Pazaitou-Panayiotou K, Papapetrou PD, Chrisoulidou A, et al. Height, whole body surface area, gender, working outdoors, and sunbathing in previous summer are important determinants of serum 25-hydroxyvitamin D levels. Exp Clin Endocrinol Diabetes 2012;120:14-22.
33. Urena-Torres P, Metzger M, Haymann JP, et al. Association of kidney function, vitamin D deficiency, and circulating markers of mineral and bone disorders in CKD. Am J Kidney Dis 2011;58:544-53.
34. Agmon-Levin N, Blank M, Zandman-Goddard G, et al. Vitamin D: An instrumental factor in the anti-phospholipid syndrome by inhibition of tissue factor expression. Ann Rheum Dis 2011;70:145-50.
35. Andreoli L, Piantoni S, Dall'Ara F, et al. Vitamin D and antiphospholipid syndrome. Lupus 2012;21:736-40.
36. Paupitz JA, Freire de Carvalho J, Caparbo VF, et al. Primary antiphospholipid syndrome in premenopausal women: low vitamin D, high fat mass and maintained bone mineral mass. Lupus 2010;19:1302-6.
37. Rulcova A, Prokopova I, Krausova L, et al. Stereoselective interactions of warfarin enantiomers with Pregnane X nuclear (PXR) receptor in gene regulation of major drug-metabolizing cytochrome P450 enzymes. J Thromb Haemost 2010;8:2708-17.
38. Zhou C, Assem M, Tay JC, et al. Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia. J Clin Invest 2006;116:1703-12.
39. Costedoat-Chalumeau N, Amoura Z, Hulot JS, et al. Hydroxychloroquine in systemic lupus erythematosus. Lancet 2007;369:1257-8.
40. Costedoat-Chalumeau N, Leroux G, Piette J-C, et al. Antimalarials and systemic lupus erythematosus. In: Lahita RG, Tsokos G, Buyon JP, Koike T. eds. Systemic lupus erythematosus. 5th edn. Elsevier, 2010:1061-81.
41. Lakshminarayanan S, Walsh S, Mohanraj M, et al. Factors associated with low bone mineral density in female patients with systemic lupus erythematosus. J Rheumatol 2001; 28:102-8.
42. Mok CC, Mak A, Ma KM. Bone mineral density in postmenopausal Chinese patients with systemic lupus erythematosus. Lupus 2005;14:106-12.
43. Barre PE, Gascon-Barre M, Meakins JL, et al. Hydroxychloroquine treatment of hypercalcemia in a patient with sarcoidosis undergoing hemodialysis. Am J Med 1987;82:1259-62.
44. Adams JS, Diz MM, Sharma OP. Effective reduction in the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia with short-course chloroquine therapy. Ann Intern Med 1989;111:437-8.
45. O'Leary TJ, Jones G, Yip A, et al. The effects of chloroquine on serum 1,25-dihydroxyvitamin D and calcium metabolism in sarcoidosis. N Engl J Med 1986;315:727-30.
46. Mok CC, Birmingham DJ, Leung HW, et al. Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis. Rheumatology (Oxford) 2012;51:644-52.
47. Petri M, Bello KJ, Fang H, et al. Vitamin D in SLE: modest association with disease activity and urine protein/creatinine ratio. Arthritis Rheum 2013;65:1865-71.
48. Orbach H, Zandman-Goddard G, Amital H, et al. Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann N Y Acad Sci 2007;1109:385-400.
49. Toloza SM, Cole DE, Gladman DD, et al. Vitamin D insufficiency in a large female SLE cohort. Lupus 2010;19:13-19.
50. Ruiz-Irastorza G, Gordo S, Olivares N, et al. Changes in vitamin D levels in patients with systemic lupus erythematosus: Effects on fatigue, disease activity, and damage. Arthritis Care Res (Hoboken) 2010;62:1160-5.
51. Birmingham DJ, Hebert LA, Song H, et al. Evidence that abnormally large seasonal declines in vitamin D status may trigger SLE flare in non-African Americans. Lupus 2012;21:855-64.
52. Souberbielle JC, Body JJ, Lappe JM, et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun Rev 2010;9:709-15.
53. Abou-Raya A, Abou-Raya S, Helmii M. The effect of vitamin D supplementation on inflammatory and hemostatic markers and disease activity in patients with systemic lupus erythematosus: A randomized placebo-controlled trial. J Rheumatol 2013;40:265-72.